Skip to content

Clinical trials

Phase 4 Multiple Sclerosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 4 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20111
20121
20133
20142
20153
20171
20183
20192
20213
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Biogen2
Hoffmann-La Roche2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2
Merck KGaA, Darmstadt, Germany2
Novartis Pharmaceuticals2
University Hospital, Strasbourg, France2
University Hospital, Toulouse2
Astellas Pharma Inc1
Centre Hospitalier Régional d'Orléans1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis25
Multiple Sclerosis, Relapsing-Remitting3
Fatigue2
Acquired Immunodeficiency Syndrome1
Anxiety Disorders1
Chickenpox1
Diabetes Mellitus, Type 21
Hematologic Neoplasms1
Herpes Zoster1
Hypergammaglobulinemia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.